GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+7.91%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$388M
AUM Growth
+$388M
Cap. Flow
+$40.8M
Cap. Flow %
10.53%
Top 10 Hldgs %
49.94%
Holding
61
New
17
Increased
14
Reduced
13
Closed
10

Top Buys

1
TSRO
TESARO, Inc.
TSRO
$17.6M
2
FXF icon
Invesco CurrencyShares Swiss Franc Trust
FXF
$12.3M
3
ECYT
Endocyte, Inc. Common Stock
ECYT
$10.7M
4
TVTX icon
Travere Therapeutics
TVTX
$10.1M
5
ZGNX
Zogenix, Inc.
ZGNX
$9.92M

Top Sells

1
MRSN icon
Mersana Therapeutics
MRSN
$10.7M
2
ARWR icon
Arrowhead Research
ARWR
$9.52M
3
GBT
Global Blood Therapeutics, Inc.
GBT
$8.74M
4
EXEL icon
Exelixis
EXEL
$8.61M
5
PTCT icon
PTC Therapeutics
PTCT
$8.23M

Sector Composition

1 Healthcare 82.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CBIO
26
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$5.76M 1.22%
400,000
– –
KALV icon
27
KalVista Pharmaceuticals
KALV
$713M
$4.98M 1.06%
+225,000
New +$4.98M
BDSI
28
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.2M 0.89%
1,500,000
+88,753
+6% +$249K
KURA icon
29
Kura Oncology
KURA
$732M
$4.03M 0.86%
230,000
– –
BCRX icon
30
BioCryst Pharmaceuticals
BCRX
$1.74B
$3.82M 0.81%
+500,000
New +$3.82M
UROV
31
DELISTED
Urovant Sciences Ltd.
UROV
$3.6M 0.77%
+300,000
New +$3.6M
RDUS
32
DELISTED
Radius Health, Inc.
RDUS
$3.56M 0.76%
+200,000
New +$3.56M
ALLK
33
DELISTED
Allakos
ALLK
$3.37M 0.72%
+75,000
New +$3.37M
APLS icon
34
Apellis Pharmaceuticals
APLS
$3.51B
$3.29M 0.7%
185,000
– –
MDGL icon
35
Madrigal Pharmaceuticals
MDGL
$9.7B
$3.04M 0.65%
14,200
-9,300
-40% -$1.99M
ARVN icon
36
Arvinas
ARVN
$580M
$2.95M 0.63%
+175,000
New +$2.95M
GNCA
37
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.75M 0.58%
3,525,000
– –
NEOS
38
DELISTED
Neos Therapeutics, Inc
NEOS
$2.34M 0.5%
482,600
-117,400
-20% -$569K
GYRE icon
39
Gyre Therapeutics
GYRE
$734M
$2.16M 0.46%
200,000
-155,000
-44% -$1.67M
AVDL
40
Avadel Pharmaceuticals
AVDL
$1.42B
$1.98M 0.42%
450,000
– –
NGNE icon
41
Neurogene
NGNE
$284M
$1.47M 0.31%
+500,000
New +$1.47M
SAGE
42
DELISTED
Sage Therapeutics
SAGE
$1.34M 0.29%
+9,500
New +$1.34M
FATE icon
43
Fate Therapeutics
FATE
$115M
$1.22M 0.26%
+75,000
New +$1.22M
GRTS
44
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.07M 0.23%
+75,000
New +$1.07M
PDSB icon
45
PDS Biotechnology
PDSB
$60.6M
$820K 0.17%
1,000,000
+249,208
+33% +$204K
SPPI
46
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$793K 0.17%
47,200
+18,200
+63% +$306K
INSM icon
47
Insmed
INSM
$30.3B
$526K 0.11%
+26,000
New +$526K
MOTS
48
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$510K 0.11%
100,000
– –
GBT
49
DELISTED
Global Blood Therapeutics, Inc.
GBT
$456K 0.1%
12,000
-230,000
-95% -$8.74M
TGTX icon
50
TG Therapeutics
TGTX
$5.03B
$255K 0.05%
45,500
-6,500
-13% -$36.4K
1
2
3